Abbott India Ltd
The live share price of Abbott India Ltd (ABBOTINDIA) as on 30 May 9:59am is ₹22,054.6 from NSE/BSE.
ABBOTINDIA NSE
₹22,054.6 ▲0.73% (160.8)
As on May 30, 2023 03:29 PM IST
Key Metrics
PE Ratio
49
PB Ratio
16.5
Dividend Yield
-
Sector PB
4.49
Sector PE
33.72
Sector Div Yld
0.82%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Sector
Health Care
Industry
Pharmaceuticals
Market Cap
Midcap, ₹46,522 Cr
Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
The following charts display the financial performance of the Abbott India Ltd (ABBOTINDIA) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Abbott India Ltd (ABBOTINDIA), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Sector
Health Care
Industry
Pharmaceuticals
Market Cap
Midcap, ₹46,522 Cr
Financials
Income Statement
| (INR) | Y/Y Change | |
| Revenue | 5,502 Cr | +10.14% |
| Operating Expense | 4,143 Cr | +3420.35% |
| Net Income | 949 Cr | +18.87% |
| Net Profit Margin | 17.25% | +7.88% |
| Earning Per Share | 446 | +18.87% |
| EBITDA | 1,359 Cr | +16.73% |
Balance sheet
| (INR) | Y/Y Change | |
| Cash & short-term Inv | 2,749 Cr | +14.12% |
| Total Assets | 4,224 Cr | +9.99% |
| Total Liabilities | 1,404 Cr | +13.41% |
| Total Equity | 2,819 Cr | +8.36% |
| Shares Outstanding | 2.12 Cr | -0.23% |
| Price to Book | 13.2 | +7.91% |
| Return on Assets | 19.81% | +5.94% |
| Return on Capital | 38.97 Cr | +7.38% |
Cash Flows
| (INR) | Y/Y Change | |
| Net Income | 949 Cr | +18.87% |
| Cash from Operations | 947 Cr | +30.4% |
| Cash from Investing | -395 Cr | +451.16% |
| Cash from Financing | -637 Cr | +9.55% |
| Net Change in Cash | -85 Cr | -217% |
| Free Cash Flow | 903 Cr | +28.45% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
27.27
1Y Return
▲8.03%
CIPLA
Cipla Ltd
PE Ratio
27.52
1Y Return
▼-2.73%
DRREDDY
Dr Reddy's Laboratories Ltd
PE Ratio
16.8
1Y Return
▲3.4%
TORNTPHARM
Torrent Pharmaceuticals Ltd
PE Ratio
69.48
1Y Return
▲18.78%
Latest News
Abbott, other baby-formula producers under FTC investigation for collusion By Investing.com
7 days ago on Investing.com
Change since news ▼-2.54%
Abbott, other baby-formula producers under FTC investigation for collusion
Buy Abbott India; target of Rs 25,243: Sharekhan
7 days ago on Moneycontrol
Change since news ▼-2.54%
Sharekhan is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 25,243 in its research report dated May 19, 2023.
Trade setup for Tuesday: Top 15 things to know before the opening bell
1 week ago on Moneycontrol
Change since news 0%
Based on the OI percentage, 71 stocks were on the short-covering list. These included IRCTC, Abbott India, Aarti Industries, Divis Laboratories, and Balrampur Chini Mills.
FAQs on Abbott India Ltd
How to buy Abbott India Ltd stocks?
You can easily buy the stocks/shares of Abbott India Ltd (ABBOTINDIA) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Abbott India Ltd?
The stock price of Abbott India Ltd as on 30 May 2023 is ₹22,054.6
What is the 52-week High and Low of Abbott India Ltd?
The 52-week high and low of Abbott India Ltd (ABBOTINDIA) is ₹23,140 and ₹17,325.
What is the PE and PB ratio of Abbott India Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Abbott India Ltd are 49 and 16.5 respectively.
What are the peers or stocks similar to Abbott India Ltd?
The peers or stocks similar to Abbott India Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Abbott India Ltd belong to?
Abbott India Ltd (ABBOTINDIA) belongs to the Pharmaceuticals sector.
What is the Market Cap of Abbott India Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Abbott India Ltd (ABBOTINDIA) is ₹46,522 Cr as of 30 May 2023
Can't decide whether or not to buy Abbott India Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.
smallcase Technologies Private Limited
#51, 3rd Floor, Le Parc Richmonde,
Richmond Road, Shanthala Nagar,
Richmond Town, Bangalore - 560025